Robert Foust
Gastroenterology · Concord, NCNPI 1649289521
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 257 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 25.2% of the total. Reporting peaked in 2019 at $1,503 and has fallen 95.0% since, to $76 in 2022.
Across 257 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$866
- Gilead$320
- Takeda Pharmaceuticals U.S.A., Inc.$298
- Alnylam Pharmaceuticals Inc.$190
- Pfizer$186
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,999100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $1,006 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 53 | $866 |
| Gilead | 31 | $320 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $298 |
| Alnylam Pharmaceuticals Inc. | 11 | $190 |
| Pfizer | 12 | $186 |
| Amgen | 9 | $163 |
| Intercept Pharmaceuticals, Inc. | 10 | $152 |
| UCB, Inc. | 9 | $147 |
| Nestle Healthcare Nutrition Inc. | 7 | $121 |
| Ironwood Pharmaceuticals, Inc | 6 | $92 |
| Braintree Laboratories, Inc. | 6 | $83 |
| QOL Medical, LLC | 5 | $80 |
| Johnson & Johnson(2 entities) | 5 | $79 |
| Shire North American Group Inc | 4 | $60 |
| Merck | 4 | $58 |
| Ferring Pharmaceuticals Inc. | 3 | $41 |
| Bristol Myers Squibb | 2 | $40 |
| Alfasigma USA, Inc. | 1 | $17 |
How this compares
$3,999 in reported general payments places this provider in the 60th percentile of 610 gastroenterology providers in North Carolina.
Other gastroenterology in Concord
- Stephen DealCharlotte$945K
- Fred FowlerCharlotte$932K
- Paul WatkinsChapel Hill$876K
- Nilesh LodhiaCharlotte$735K
- Evan DellonChapel Hill$431K
- Robert ReindollarSalisbury$430K
- Andrew StormWinston Salem$426K
- John PoulosFayetteville$407K
- Manal AbdelmalekDurham$402K
- Christopher McGowanCary$223K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.